We are pleased to announce the launch of EpidStrategies, a new division of ToxStrategies. With this expansion, ToxStrategies is adding world-class epidemiology expertise to its offering of consulting services. The scientists and biostatisticians at EpidStrategies can assist clients in addressing complex health issues and in conducting and evaluating epidemiological studies, from design through the interpretation of results. The EpidStrategies team is adept at applying these tools to assessments in such diverse arenas as pharmaceuticals, medical devices, and environmental chemicals. Dr. Jon Fryzek will lead the EpidStrategies team along with Sarah Cohen, Ph.D. Other team members include Lauren Bylsma, MPH, Xiaohui Jiang, MS, and Heidi Reichert, MS, MA.